Benign Prostatic Hyperplasia
Open Access
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (1) , 66-81
- https://doi.org/10.2165/00003495-199447010-00005
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- FinasterideDrugs, 1993
- Economic Burden of Treated Benign Prostatic Hyperplasia in the United KingdomBritish Journal of Urology, 1993
- AlfuzosinDrugs, 1993
- TerazosinDrugs & Aging, 1993
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasiaThe Prostate, 1990
- New alpha1-adrenergic receptor antagonists for the treatment of hypertension: Role of vascular alpha receptors in the control of peripheral resistanceAmerican Heart Journal, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982